 Liudmila Kulik
Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Complement 3d | 14 | 2017 | 141 | 1.900 |
Why?
| | Immunoglobulin M | 17 | 2023 | 276 | 1.770 |
Why?
| | Antibodies, Monoclonal | 10 | 2023 | 1363 | 1.310 |
Why?
| | Complement C3d | 5 | 2023 | 65 | 1.110 |
Why?
| | B-Lymphocytes | 12 | 2017 | 815 | 0.820 |
Why?
| | Reperfusion Injury | 7 | 2021 | 271 | 0.780 |
Why?
| | Receptors, Complement 3b | 4 | 2020 | 84 | 0.770 |
Why?
| | Glutamic Acid | 1 | 2023 | 234 | 0.720 |
Why?
| | Complement Activation | 11 | 2020 | 381 | 0.670 |
Why?
| | Epitopes | 9 | 2023 | 470 | 0.660 |
Why?
| | Antigen-Antibody Complex | 1 | 2019 | 85 | 0.650 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2019 | 247 | 0.540 |
Why?
| | Immune System Diseases | 1 | 2015 | 34 | 0.460 |
Why?
| | Arthritis, Experimental | 5 | 2020 | 135 | 0.460 |
Why?
| | Kidney Glomerulus | 4 | 2021 | 109 | 0.450 |
Why?
| | Mice | 31 | 2023 | 16905 | 0.410 |
Why?
| | Autoantibodies | 7 | 2019 | 1467 | 0.390 |
Why?
| | Mice, Knockout | 15 | 2019 | 2871 | 0.350 |
Why?
| | Kidney Diseases | 3 | 2023 | 382 | 0.350 |
Why?
| | Annexin A4 | 2 | 2015 | 6 | 0.350 |
Why?
| | Models, Immunological | 1 | 2011 | 95 | 0.350 |
Why?
| | Animals | 36 | 2023 | 35286 | 0.350 |
Why?
| | Antibody Formation | 4 | 2010 | 291 | 0.340 |
Why?
| | Complement C3 | 7 | 2021 | 208 | 0.330 |
Why?
| | Glomerulonephritis | 2 | 2023 | 46 | 0.320 |
Why?
| | Mice, Inbred C57BL | 17 | 2020 | 5438 | 0.300 |
Why?
| | Immunity, Innate | 4 | 2015 | 803 | 0.300 |
Why?
| | Single-Chain Antibodies | 2 | 2020 | 17 | 0.290 |
Why?
| | Glomerulosclerosis, Focal Segmental | 2 | 2021 | 43 | 0.280 |
Why?
| | Antibodies | 2 | 2017 | 398 | 0.250 |
Why?
| | Complement System Proteins | 2 | 2021 | 317 | 0.250 |
Why?
| | Complement Factor H | 2 | 2018 | 72 | 0.250 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 589 | 0.220 |
Why?
| | Cell Differentiation | 4 | 2007 | 1888 | 0.210 |
Why?
| | Sheep | 5 | 2015 | 838 | 0.210 |
Why?
| | Receptors, Antigen, B-Cell | 3 | 2011 | 126 | 0.210 |
Why?
| | Annexins | 1 | 2023 | 3 | 0.210 |
Why?
| | Racemethionine | 1 | 2023 | 3 | 0.210 |
Why?
| | Receptors, Complement | 3 | 2022 | 122 | 0.210 |
Why?
| | Immunoglobulin G | 5 | 2023 | 848 | 0.210 |
Why?
| | Immunity, Humoral | 2 | 2015 | 118 | 0.210 |
Why?
| | Complement C3b | 1 | 2023 | 32 | 0.210 |
Why?
| | Antibody Specificity | 4 | 2021 | 184 | 0.210 |
Why?
| | Protein Multimerization | 2 | 2021 | 178 | 0.200 |
Why?
| | Foot-and-Mouth Disease | 1 | 2022 | 1 | 0.200 |
Why?
| | Foot-and-Mouth Disease Virus | 1 | 2022 | 1 | 0.200 |
Why?
| | Methionine | 1 | 2023 | 155 | 0.200 |
Why?
| | Antigens, CD19 | 2 | 2015 | 114 | 0.200 |
Why?
| | Erythrocytes | 4 | 2015 | 673 | 0.190 |
Why?
| | B-Lymphocyte Subsets | 3 | 2010 | 74 | 0.190 |
Why?
| | Complement Pathway, Classical | 1 | 2021 | 18 | 0.190 |
Why?
| | Nephrosis, Lipoid | 1 | 2021 | 10 | 0.190 |
Why?
| | Nephrotic Syndrome | 1 | 2021 | 28 | 0.180 |
Why?
| | Lymphocyte Activation | 4 | 2021 | 1109 | 0.180 |
Why?
| | Cardiolipins | 1 | 2021 | 83 | 0.180 |
Why?
| | Disease Models, Animal | 5 | 2019 | 4056 | 0.180 |
Why?
| | Transplants | 1 | 2021 | 35 | 0.180 |
Why?
| | Synoviocytes | 1 | 2020 | 11 | 0.170 |
Why?
| | Autoimmunity | 3 | 2019 | 862 | 0.170 |
Why?
| | Protein Processing, Post-Translational | 1 | 2023 | 454 | 0.170 |
Why?
| | Complement Inactivating Agents | 2 | 2021 | 46 | 0.170 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2019 | 38 | 0.170 |
Why?
| | Mice, Transgenic | 7 | 2011 | 2117 | 0.160 |
Why?
| | Joints | 1 | 2020 | 101 | 0.160 |
Why?
| | Single Photon Emission Computed Tomography Computed Tomography | 1 | 2019 | 10 | 0.160 |
Why?
| | Iodine Radioisotopes | 1 | 2019 | 142 | 0.150 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2019 | 186 | 0.150 |
Why?
| | Cattle | 3 | 2022 | 977 | 0.150 |
Why?
| | Clonal Anergy | 2 | 2011 | 51 | 0.150 |
Why?
| | Mice, Inbred DBA | 4 | 2020 | 190 | 0.150 |
Why?
| | Lung Injury | 1 | 2021 | 210 | 0.150 |
Why?
| | Lung Transplantation | 1 | 2021 | 289 | 0.150 |
Why?
| | Protein Binding | 3 | 2019 | 2120 | 0.140 |
Why?
| | Antirheumatic Agents | 1 | 2020 | 280 | 0.140 |
Why?
| | Complement C4b-Binding Protein | 1 | 2017 | 3 | 0.140 |
Why?
| | Tetanus Toxin | 1 | 2017 | 6 | 0.140 |
Why?
| | Kidney | 3 | 2023 | 1384 | 0.140 |
Why?
| | Ligands | 1 | 2019 | 620 | 0.140 |
Why?
| | Vaccines, Synthetic | 1 | 2017 | 126 | 0.140 |
Why?
| | Inflammation Mediators | 1 | 2019 | 504 | 0.130 |
Why?
| | Complement Pathway, Alternative | 2 | 2018 | 119 | 0.130 |
Why?
| | Models, Molecular | 1 | 2021 | 1485 | 0.130 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 86 | 0.130 |
Why?
| | Endothelial Cells | 1 | 2021 | 746 | 0.130 |
Why?
| | Tuberculosis | 1 | 2019 | 273 | 0.130 |
Why?
| | Mycobacterium tuberculosis | 1 | 2019 | 309 | 0.120 |
Why?
| | Down-Regulation | 3 | 2015 | 636 | 0.120 |
Why?
| | Antigens | 2 | 2015 | 356 | 0.120 |
Why?
| | Self Tolerance | 1 | 2015 | 28 | 0.120 |
Why?
| | Immunoglobulin D | 1 | 2015 | 29 | 0.120 |
Why?
| | Phospholipids | 2 | 2015 | 215 | 0.120 |
Why?
| | Myocardial Reperfusion | 1 | 2015 | 50 | 0.120 |
Why?
| | Humans | 20 | 2023 | 129144 | 0.110 |
Why?
| | Antibodies, Bispecific | 1 | 2015 | 49 | 0.110 |
Why?
| | Lymphocyte Depletion | 2 | 2013 | 131 | 0.110 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2015 | 129 | 0.110 |
Why?
| | Spinal Cord Injuries | 1 | 2017 | 194 | 0.110 |
Why?
| | Peptide Fragments | 1 | 2017 | 692 | 0.110 |
Why?
| | Cell Death | 1 | 2015 | 354 | 0.100 |
Why?
| | Complement C1q | 1 | 2013 | 37 | 0.100 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2013 | 26 | 0.100 |
Why?
| | Lymphocyte Count | 2 | 2011 | 148 | 0.100 |
Why?
| | Retinal Pigment Epithelium | 1 | 2013 | 70 | 0.100 |
Why?
| | Craniocerebral Trauma | 1 | 2014 | 151 | 0.100 |
Why?
| | Genes, RAG-1 | 1 | 2012 | 12 | 0.100 |
Why?
| | Immunosuppressive Agents | 2 | 2021 | 854 | 0.100 |
Why?
| | Head Injuries, Closed | 1 | 2012 | 49 | 0.090 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 400 | 0.090 |
Why?
| | Cytokines | 1 | 2019 | 2012 | 0.090 |
Why?
| | Amidines | 1 | 2011 | 16 | 0.090 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2011 | 17 | 0.090 |
Why?
| | Ornithine | 1 | 2011 | 25 | 0.090 |
Why?
| | Peritoneum | 1 | 2011 | 41 | 0.090 |
Why?
| | Adaptive Immunity | 1 | 2012 | 161 | 0.090 |
Why?
| | Mice, Inbred BALB C | 3 | 2023 | 1246 | 0.090 |
Why?
| | Hydrolases | 1 | 2011 | 56 | 0.090 |
Why?
| | Female | 9 | 2023 | 68494 | 0.090 |
Why?
| | Biomarkers | 2 | 2019 | 3963 | 0.090 |
Why?
| | Injections | 1 | 2011 | 174 | 0.080 |
Why?
| | Transgenes | 1 | 2011 | 177 | 0.080 |
Why?
| | Acute Kidney Injury | 1 | 2018 | 789 | 0.080 |
Why?
| | Germinal Center | 3 | 2022 | 57 | 0.080 |
Why?
| | Graft Rejection | 1 | 2013 | 598 | 0.080 |
Why?
| | Chronic Disease | 1 | 2015 | 1714 | 0.080 |
Why?
| | Peptides, Cyclic | 2 | 2011 | 256 | 0.080 |
Why?
| | Heart Transplantation | 1 | 2015 | 721 | 0.080 |
Why?
| | Brain Ischemia | 1 | 2011 | 321 | 0.070 |
Why?
| | Inflammation | 2 | 2016 | 2735 | 0.070 |
Why?
| | Organ Specificity | 3 | 2016 | 295 | 0.070 |
Why?
| | Doxorubicin | 2 | 2023 | 328 | 0.070 |
Why?
| | Enzyme Inhibitors | 1 | 2011 | 827 | 0.070 |
Why?
| | Lymphoid Tissue | 1 | 2007 | 67 | 0.070 |
Why?
| | Dendritic Cells, Follicular | 2 | 2022 | 5 | 0.070 |
Why?
| | Extracellular Space | 1 | 2007 | 120 | 0.070 |
Why?
| | Kidney Transplantation | 1 | 2013 | 670 | 0.070 |
Why?
| | Lymphopenia | 2 | 2007 | 60 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2013 | 1265 | 0.060 |
Why?
| | Rats | 1 | 2015 | 5479 | 0.060 |
Why?
| | Homeodomain Proteins | 3 | 2015 | 493 | 0.060 |
Why?
| | Male | 12 | 2021 | 63456 | 0.060 |
Why?
| | Signal Transduction | 2 | 2011 | 4919 | 0.060 |
Why?
| | Cell Line | 3 | 2017 | 2775 | 0.060 |
Why?
| | Recombinant Fusion Proteins | 2 | 2020 | 648 | 0.060 |
Why?
| | Amino Acid Sequence | 1 | 2009 | 2056 | 0.060 |
Why?
| | Interferon-alpha | 1 | 2006 | 194 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 2021 | 1304 | 0.060 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2835 | 0.060 |
Why?
| | Stroke | 1 | 2011 | 1070 | 0.050 |
Why?
| | Adjuvants, Immunologic | 2 | 2017 | 221 | 0.050 |
Why?
| | Agammaglobulinemia | 1 | 2002 | 33 | 0.050 |
Why?
| | Brain | 1 | 2014 | 2668 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2012 | 1932 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2009 | 3186 | 0.050 |
Why?
| | Arthritis, Rheumatoid | 2 | 2011 | 1097 | 0.050 |
Why?
| | Capsid Proteins | 1 | 2022 | 90 | 0.050 |
Why?
| | In Situ Nick-End Labeling | 2 | 2012 | 123 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 108 | 0.040 |
Why?
| | Stem Cells | 1 | 2005 | 574 | 0.040 |
Why?
| | Proteolysis | 1 | 2021 | 167 | 0.040 |
Why?
| | Thymocytes | 1 | 2020 | 34 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2021 | 543 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 102 | 0.040 |
Why?
| | Antibodies, Neutralizing | 1 | 2022 | 265 | 0.040 |
Why?
| | DNA | 1 | 2006 | 1396 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2021 | 217 | 0.040 |
Why?
| | Lymphocytes | 1 | 2021 | 378 | 0.040 |
Why?
| | Spleen | 2 | 2013 | 506 | 0.040 |
Why?
| | Aging | 1 | 2009 | 1774 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2019 | 315 | 0.040 |
Why?
| | Blotting, Western | 2 | 2012 | 1202 | 0.040 |
Why?
| | Protein Conformation | 1 | 2021 | 860 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2020 | 4075 | 0.040 |
Why?
| | Synovial Membrane | 2 | 2011 | 90 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2022 | 601 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1678 | 0.030 |
Why?
| | Apoptosis | 2 | 2020 | 2491 | 0.030 |
Why?
| | Locomotion | 1 | 2017 | 100 | 0.030 |
Why?
| | Time Factors | 3 | 2015 | 6541 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 376 | 0.030 |
Why?
| | Genes, Synthetic | 1 | 2015 | 15 | 0.030 |
Why?
| | Transplantation Tolerance | 1 | 2015 | 35 | 0.030 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2014 | 26 | 0.030 |
Why?
| | Albuminuria | 1 | 2015 | 183 | 0.030 |
Why?
| | fas Receptor | 1 | 2014 | 94 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3372 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2016 | 325 | 0.030 |
Why?
| | Complement C3-C5 Convertases | 1 | 2013 | 22 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 390 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 232 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 88 | 0.030 |
Why?
| | Oxidants | 1 | 2013 | 109 | 0.020 |
Why?
| | Choroidal Neovascularization | 1 | 2013 | 55 | 0.020 |
Why?
| | Astrocytes | 1 | 2014 | 195 | 0.020 |
Why?
| | Rituximab | 1 | 2013 | 164 | 0.020 |
Why?
| | Microglia | 1 | 2014 | 232 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 317 | 0.020 |
Why?
| | Protein-Arginine Deiminases | 1 | 2011 | 16 | 0.020 |
Why?
| | Collagen Type II | 1 | 2011 | 48 | 0.020 |
Why?
| | Blood-Brain Barrier | 1 | 2012 | 131 | 0.020 |
Why?
| | Citrulline | 1 | 2011 | 43 | 0.020 |
Why?
| | Myocardium | 1 | 2015 | 978 | 0.020 |
Why?
| | Vaccination | 1 | 2017 | 1347 | 0.020 |
Why?
| | Lymphocyte Subsets | 1 | 2009 | 84 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2010 | 398 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2009 | 160 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 832 | 0.020 |
Why?
| | Bone Marrow Cells | 1 | 2009 | 302 | 0.020 |
Why?
| | Immune System | 1 | 2009 | 175 | 0.020 |
Why?
| | Species Specificity | 1 | 2009 | 574 | 0.020 |
Why?
| | Receptors, HIV | 1 | 2007 | 25 | 0.020 |
Why?
| | Binding Sites, Antibody | 1 | 2007 | 42 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2622 | 0.020 |
Why?
| | Antibodies, Blocking | 1 | 2007 | 33 | 0.020 |
Why?
| | K562 Cells | 1 | 2007 | 85 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 10192 | 0.020 |
Why?
| | Virion | 1 | 2007 | 82 | 0.020 |
Why?
| | Lupus Vulgaris | 1 | 2006 | 4 | 0.020 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 52 | 0.020 |
Why?
| | Lung | 1 | 2019 | 3927 | 0.020 |
Why?
| | HIV | 1 | 2007 | 227 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 584 | 0.020 |
Why?
| | Neurons | 1 | 2014 | 1493 | 0.020 |
Why?
| | Fibrinogen | 1 | 2006 | 163 | 0.010 |
Why?
| | Autoimmune Diseases | 1 | 2009 | 426 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 12385 | 0.010 |
Why?
| | Hyaluronan Receptors | 1 | 2005 | 96 | 0.010 |
Why?
| | Collagen | 1 | 2006 | 433 | 0.010 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2005 | 363 | 0.010 |
Why?
| | Erythrocyte Transfusion | 1 | 2005 | 181 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2736 | 0.010 |
Why?
| | Leukotriene B4 | 1 | 2002 | 42 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2002 | 142 | 0.010 |
Why?
| | Aged | 1 | 2021 | 21997 | 0.010 |
Why?
| | Up-Regulation | 1 | 2005 | 838 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2005 | 877 | 0.010 |
Why?
| | Immunophenotyping | 1 | 2002 | 310 | 0.010 |
Why?
| | Phenotype | 1 | 2009 | 3071 | 0.010 |
Why?
| | Middle Aged | 1 | 2021 | 31050 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 2002 | 412 | 0.010 |
Why?
| | Intestines | 1 | 2002 | 347 | 0.010 |
Why?
| | Adult | 1 | 2021 | 35469 | 0.010 |
Why?
| | HIV Infections | 1 | 2007 | 2721 | 0.010 |
Why?
|
|
Kulik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|